Trials / Completed
CompletedNCT02622022
Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 110 Years
- Healthy volunteers
- Not accepted
Summary
36 patients with interstitial lung disease will be randomized to 1 weeks treatment with morphine hydrochloride as oral linctus 5 mg, four times a day, and 5 mg as needed up to 4 times a day, or corresponding doses of placebo. VAS score for dyspnea will be evaluated after 1 hour and 1 week at follow up. Other questionnaires will also be evaluated (GAD-7, K-BUILD, Leicester score)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphine hydrochloride | |
| OTHER | Placebo |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2019-02-06
- Completion
- 2019-02-06
- First posted
- 2015-12-04
- Last updated
- 2019-04-10
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02622022. Inclusion in this directory is not an endorsement.